KoreaTimes - Bio

The Korea Times

Entertainment & Arts

SCMP
Asia

The Korea Times

Entertainment & Arts

SCMP
Asia

The Korea Times

Business

Bio

Sun, February 5, 2023 | 16:14

[INTERVIEW] Korea should strengthen ecosystem for clinical trials

INTERVIEWKorea should strengthen ecosystem for clinical trials

Over the last few years, the government has been supporting its strategy to help the country rise as a biotechnology hub in Asia given Korea's long-time competiveness in product manufacturing. The country's advantages in terms of having excellent infrastructure, workforce and IT platform have truly been beneficial amid COVID-19 as a number of biotechnology companies, includin...

Kim Yoo-chul | 2022-06-02 15:24

Samsung Biologics establishes one-stop mRNA vaccine production capability at Songdo plant

Samsung Biologics establishes one-stop mRNA vaccine production capability at Songdo plant

Samsung Biologics, the biotech arm of Korea's Samsung Group, has established a one-stop production capability for manufacturing messenger RNA (mRNA) vaccines by newly adding an mRNA vaccine substance production facility at the plant, a company official said Thursday.

2022-06-02 11:21

[INTERVIEW] Immunomic Therapeutics CEO expects meaningful test results for brain tumor drug

INTERVIEWImmunomic Therapeutics CEO expects meaningful test results for brain tumor drug

William Hearl, CEO of Immunomic Therapeutics, the U.S. subsidiary of the Korean biotech company, HLB, said that the company expects meaningful test results from its Phase 2 clinical trials of a drug for glioblastoma by August of this year at the latest.

Baek Byung-yeul | 2022-05-26 16:03

HLB gets positive Phase 3 data with liver cancer treatment

HLB gets positive Phase 3 data with liver cancer treatment

HLB has taken a step closer to the global commercialization of its anticancer treatment Rivoceranib as it secured statistical significance in Phase 3 global clinical trials of the drug, according to the local biotech company, Sunday.

Baek Byung-yeul | 2022-05-15 16:23

Lotte seeks to acquire US CMO plant to enter bioindustry

Lotte seeks to acquire US CMO plant to enter bioindustry

Lotte Group is in the process of acquiring a bioindustry contract manufacturing (CMO) plant in the U.S., according to the investment banking industry, Thursday. The move comes after the conglomerate declared the bioindustry as its new growth engine. CMOs specialize in producing biopharmaceuticals developed by other companies.

Kim Hyun-bin | 2022-05-05 14:46

CHA Biotech's US subsidiary opens CDMO plant in Texas

CHA Biotech's US subsidiary opens CDMO plant in Texas

Matica Biotechnology, a U.S. affiliate of CHA Biotech, has opened a cell and gene therapy manufacturing facility in College Station, Texas, according to the cell therapeutics and stem cell developer affiliate of CHA Medical & Bio Group, Wednesday.

Lee Kyung-min | 2022-05-04 15:53

Osstem Implant posts record profits for Q1

Osstem Implant posts record profits for Q1

Osstem Implant posted a record operating profit for the first quarter, the dental equipment manufacturer said Friday.

Baek Byung-yeul | 2022-04-29 16:30

HLB posts earnings surprise in Q1

HLB posts earnings surprise in Q1

Local biotech company HLB posted sales and operating profit records for the first quarter. The company announced on April 25 that its quarterly sales rose a whopping 1,052 percent from the same period in 2021 to 63.4 billion won ($50.8 million). Its operating profit also came to 18.8 billion won to turn into a surplus. Both sales and operating profit figures were the highest ...

Baek Byung-yeul | 2022-04-26 15:12

Moon hails Phase 3 trial of SK Bioscience's COVID-19 vaccine

Moon hails Phase 3 trial of SK Bioscience's COVID-19 vaccine

President Moon Jae-in praised a successful Phase 3 trial of the nation's first homegrown COVID-19 vaccine, developed by SK Bioscience, Tuesday.

2022-04-26 15:09

Yoon to visit headquarters of homegrown COVID-19 vaccine

Yoon to visit headquarters of homegrown COVID-19 vaccine

President-elect Yoon Suk-yeol will visit homegrown vaccine producer SK Bioscience on Monday and emphasize vaccine sovereignty amid the country's fight against the novel coronavirus, his spokesperson said.

2022-04-25 10:58

1 2 3 4 5 6 7

Top 10 Stories

1	Teens feel peer pressure to buy luxury goods endorsed by K-pop stars

2	Itaewon tragedy's bereaved families harassed by far-right protesters

3	Discussions on raising age for free subway rides gain momentum

4	Too many emergency text alerts? Gov't to halt daily COVID-19 notifications

5	Plan to construct new memorial center for ex-president faces backlash

6	First lady expands presence in domestic politics

7	FSC OKs Apple Pay to be available in Korea

8	Naver to roll out conversational AI service

9	Able C&C sale attracts dozens of potential buyers

10	US reaffirms nuclear security assurances to South Korea

DARKROOM